Axiora Medical
Axiora Medical
Select high-performance surgical instrumentation and orthopedic implant systems engineered for critical fracture care and joint reconstruction.
An authoritative clinical and materials overview for orthopedic surgeons, procurement professionals, and medical distributors.
Total Hip Arthroplasty (THA) remains one of the most successful surgical procedures in modern medicine. In patients presenting with osteoporotic bone structure, low bone mineral density, or complex anatomical femoral geometry (such as Dorr Type C femurs), the mechanical advantages of a cemented hip prosthesis are unrivaled. By utilizing polymethyl methacrylate (PMMA) bone cement, the system achieves immediate, uniform primary mechanical stability. This technique prevents point loading, minimizes intraoperative fracture risk, and dramatically reduces early postoperative thigh pain compared to press-fit alternatives.
Modern cemented hip stems leverage high-nitrogen stainless steel (ISO 5832-9) or Cobalt-Chromium-Molybdenum (CoCrMo - ISO 5832-4) alloys. These materials feature exceptional fatigue strength to withstand high cyclical loading. The surface finish is meticulously structured; highly polished finishes (Ra < 0.1 μm) allow for controlled, minimal subsidence within the cement mantle without generating particulate debris, adhering to the proven taper-slip design principles (such as the Exeter philosophy). Composite layers and optimized geometry prevent stem rotation and axial migration.
For international medical device brands, healthcare groups, and government tenders, selecting a trusted manufacturer is paramount. Stakeholders require supply chain partners capable of offering consistent raw material traceability, advanced production capacities, and compliance with modern standards like the EU Medical Device Regulation (MDR) and FDA requirements. Supply chain resilience, cost-effective scaling, and robust OEM capabilities are critical considerations in managing risk while optimizing clinical outcomes.
Empirical proof of our advanced industrial footprint and global distribution capacity.
Inside Axiora's highly automated production lines, ensuring micron-level precision and structural longevity.
How our manufacturing cluster in China optimizes efficiency, shortens lead times, and maintains global regulatory compliance.
Navigating MDR (EU) 2017/745 and FDA regulatory pathways requires a quality management framework that ensures comprehensive biocompatibility, dynamic fatigue testing data, and absolute traceability. Axiora's operations align with ISO 13485 requirements. Our Quality Control department utilizes advanced Coordinate Measuring Machines (CMM), surface roughness testers, and dynamic fatigue testers to evaluate every batch against international regulatory standards. We supply full technical documentation (Technical Files) to facilitate rapid local registration for our global distributors.
Located in China's advanced medical manufacturing corridor, Axiora leverages direct access to premium certified raw material suppliers (medical-grade Titanium and CoCrMo alloys), specialized surface treatment centers, and efficient logistics infrastructure. This local ecosystem allows us to achieve significantly lower manufacturing costs than European or North American producers without sacrificing product quality. The result is a secure supply chain, reliable lead times, and competitive pricing for bulk procurement tenders.
We provide comprehensive OEM and ODM support, tailoring products to meet regional anatomical preferences, surgeon feedback, and competitive dynamics. From custom instrumentation trays to modified femoral stem geometries, our team of 86 R&D engineers utilizes advanced reverse engineering, 3D modeling, and rapid prototyping to bring your designs to market. We also offer private labeling, custom laser marking, and sterile packaging solutions.
From aging human patient demographics to advanced veterinary hip reconstruction.
For patients over 75 years of age presenting with osteoporosis or poor bone stock, cemented hip stems are the clinical standard. The bone cement fills the gaps within the osteoporotic trabeculae, providing immediate primary stability that allows for early postoperative mobilization. This reduces the risks of prolonged bed rest, such as deep vein thrombosis (DVT) and pulmonary complications, while ensuring excellent long-term implant survival rates.
In revision total hip arthroplasty, severe bone loss often prevents the secure placement of press-fit stems. In these cases, a cemented revision stem can bridge the structural bone defects, using PMMA bone cement to provide immediate mechanical stabilization. This approach offers a reliable solution for reconstructive challenges in revision surgeries.
High-end veterinary clinics are increasingly adopting Total Hip Replacement (THR) procedures for large canine breeds suffering from severe hip dysplasia or osteoarthritis. The mechanical properties of cemented systems are well-suited to the biomechanical forces in canine anatomy. Axiora offers specialized, downsized veterinary implants and dedicated surgical instruments to support veterinary orthopedic surgery.
Axiora Medical Technology (China) Co., Ltd. is a specialized manufacturer focused on the development, production, and global supply of premium orthopedic implants and surgical instruments.
Our product portfolio includes trauma fixation systems, spinal implants, joint reconstruction systems, sports medicine devices, and related surgical instruments. Axiora integrates advanced CNC machining, automated manufacturing lines, and strict quality control systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.
With strong OEM and ODM capabilities, we provide customized manufacturing services tailored to our clients' drawings, samples, and technical requirements. From initial design and prototyping to mass production and packaging, our integrated production process ensures consistent quality, competitive pricing, and on-time delivery. Today, Axiora exports its orthopedic products to clients across Europe, North America, South America, the Middle East, Southeast Asia, and Africa, building long-term partnerships with distributors, brand owners, hospitals, and healthcare organizations.
| Item Specification | Operational Details & Technical Values |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand | Axiora |
| Website | www.axioraortho.com |
| Established | 2017 |
| Factory Area | 18,600 m² |
| Annual Export Revenue | USD 26 Million |
| Export Experience | 8 Years |
| Industry Experience | 15 Years |
| Quality Inspection | 100% Finished Product Inspection & Incoming Material Inspection |
| Product Inspection Methods | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing |
| Quality Control Staff | 48 |
| Business Type | Manufacturer & Exporter (OEM/ODM) |
| Main Markets | Europe, North America, Middle East, Southeast Asia, South America |
| Supply Chain Partners | 1,120 |
| Main Customer Types | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Capability | Independent Product Development, Reverse Engineering, OEM & ODM Solutions |
| Customization Options | Logo Printing, Private Label, Custom Packaging, Product Design, Material Selection, Drawing-Based Manufacturing |
| New Products Released Last Year | 126 |
| R&D Engineers | 86 |
Expert technical insights regarding our manufacturing, compliance, and material specifications.
Browse our broader range of clinical orthopedic consumables, power tools, and joint replacement solutions.
